OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mapping of the binding sites for the OX1 orexin receptor antagonist, SB-334867, using orexin/hypocretin receptor chimaeras
Jaana Putula, Jyrki P. Kukkonen
Neuroscience Letters (2011) Vol. 506, Iss. 1, pp. 111-115
Closed Access | Times Cited: 29
Jaana Putula, Jyrki P. Kukkonen
Neuroscience Letters (2011) Vol. 506, Iss. 1, pp. 111-115
Closed Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Orexin/hypocretin receptor signalling cascades
Jyrki P. Kukkonen, Christopher S. Leonard
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 314-331
Open Access | Times Cited: 180
Jyrki P. Kukkonen, Christopher S. Leonard
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 314-331
Open Access | Times Cited: 180
Physiology of the orexinergic/hypocretinergic system: a revisit in 2012
Jyrki P. Kukkonen
AJP Cell Physiology (2012) Vol. 304, Iss. 1, pp. C2-C32
Closed Access | Times Cited: 133
Jyrki P. Kukkonen
AJP Cell Physiology (2012) Vol. 304, Iss. 1, pp. C2-C32
Closed Access | Times Cited: 133
Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors
Jie Yin, Kerim Babaoglu, Chad A. Brautigam, et al.
Nature Structural & Molecular Biology (2016) Vol. 23, Iss. 4, pp. 293-299
Closed Access | Times Cited: 132
Jie Yin, Kerim Babaoglu, Chad A. Brautigam, et al.
Nature Structural & Molecular Biology (2016) Vol. 23, Iss. 4, pp. 293-299
Closed Access | Times Cited: 132
Orexin/hypocretin receptor signalling: a functional perspective
Christopher S. Leonard, Jyrki P. Kukkonen
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 294-313
Open Access | Times Cited: 126
Christopher S. Leonard, Jyrki P. Kukkonen
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 294-313
Open Access | Times Cited: 126
The Hypocretin/Orexin System: An Increasingly Important Role in Neuropsychiatry
Quanhui Chen, Luı́s de Lecea, Zhian Hu, et al.
Medicinal Research Reviews (2014) Vol. 35, Iss. 1, pp. 152-197
Closed Access | Times Cited: 79
Quanhui Chen, Luı́s de Lecea, Zhian Hu, et al.
Medicinal Research Reviews (2014) Vol. 35, Iss. 1, pp. 152-197
Closed Access | Times Cited: 79
Selective orexin receptor antagonists
Terry P. Lebold, Pascal Bonaventure, Brock T. Shireman
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 17, pp. 4761-4769
Closed Access | Times Cited: 73
Terry P. Lebold, Pascal Bonaventure, Brock T. Shireman
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 17, pp. 4761-4769
Closed Access | Times Cited: 73
Orexin/Hypocretin Signaling
Jyrki P. Kukkonen
Current topics in behavioral neurosciences (2016), pp. 17-50
Open Access | Times Cited: 67
Jyrki P. Kukkonen
Current topics in behavioral neurosciences (2016), pp. 17-50
Open Access | Times Cited: 67
Hypocretin/Orexin Receptor Pharmacology and Sleep Phases
Yu Sun, Ryan K. Tisdale, Thomas S. Kilduff
Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences (2021), pp. 22-37
Open Access | Times Cited: 42
Yu Sun, Ryan K. Tisdale, Thomas S. Kilduff
Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences (2021), pp. 22-37
Open Access | Times Cited: 42
OX1 Orexin/Hypocretin Receptor Signaling through Arachidonic Acid and Endocannabinoid Release
Pauli M. Turunen, Maria Jäntti, Jyrki P. Kukkonen
Molecular Pharmacology (2012) Vol. 82, Iss. 2, pp. 156-167
Closed Access | Times Cited: 63
Pauli M. Turunen, Maria Jäntti, Jyrki P. Kukkonen
Molecular Pharmacology (2012) Vol. 82, Iss. 2, pp. 156-167
Closed Access | Times Cited: 63
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
Miles D. Thompson, Henri Xhaard, Takeshi Sakurai, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 61
Miles D. Thompson, Henri Xhaard, Takeshi Sakurai, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 61
Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics
Miles D. Thompson, Takeshi Sakurai, Innocenzo Rainero, et al.
Pharmaceuticals (2017) Vol. 10, Iss. 4, pp. 79-79
Open Access | Times Cited: 35
Miles D. Thompson, Takeshi Sakurai, Innocenzo Rainero, et al.
Pharmaceuticals (2017) Vol. 10, Iss. 4, pp. 79-79
Open Access | Times Cited: 35
Microinjection of orexin-A into the rat locus coeruleus nucleus induces analgesia via cannabinoid type-1 receptors
Hossein Mohammad-Pour Kargar, Hossein Azizi, Javad Mirnajafi‐Zadeh, et al.
Brain Research (2015) Vol. 1624, pp. 424-432
Closed Access | Times Cited: 28
Hossein Mohammad-Pour Kargar, Hossein Azizi, Javad Mirnajafi‐Zadeh, et al.
Brain Research (2015) Vol. 1624, pp. 424-432
Closed Access | Times Cited: 28
SB-334867 (an Orexin-1 Receptor Antagonist) Effects on Morphine-Induced Sensitization in Mice—a View on Receptor Mechanisms
Małgorzata Łupina, Maciej Tarnowski, Irena Baranowska‐Bosiacka, et al.
Molecular Neurobiology (2018) Vol. 55, Iss. 11, pp. 8473-8485
Open Access | Times Cited: 22
Małgorzata Łupina, Maciej Tarnowski, Irena Baranowska‐Bosiacka, et al.
Molecular Neurobiology (2018) Vol. 55, Iss. 11, pp. 8473-8485
Open Access | Times Cited: 22
Modeling of the OX1R–orexin-A complex suggests two alternative binding modes
Lasse Karhu, Ainoleena Turku, Henri Xhaard
BMC Structural Biology (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Lasse Karhu, Ainoleena Turku, Henri Xhaard
BMC Structural Biology (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Lipid signaling cascades of orexin/hypocretin receptors
Jyrki P. Kukkonen
Biochimie (2013) Vol. 96, pp. 158-165
Closed Access | Times Cited: 21
Jyrki P. Kukkonen
Biochimie (2013) Vol. 96, pp. 158-165
Closed Access | Times Cited: 21
OX2 orexin/hypocretin receptor signal transduction in recombinant Chinese hamster ovary cells
Jyrki P. Kukkonen
Cellular Signalling (2015) Vol. 28, Iss. 2, pp. 51-60
Closed Access | Times Cited: 20
Jyrki P. Kukkonen
Cellular Signalling (2015) Vol. 28, Iss. 2, pp. 51-60
Closed Access | Times Cited: 20
Pharmacophore Model To Discover OX1 and OX2 Orexin Receptor Ligands
Ainoleena Turku, Alexandre Borrel, Teppo O. Leino, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 18, pp. 8263-8275
Closed Access | Times Cited: 19
Ainoleena Turku, Alexandre Borrel, Teppo O. Leino, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 18, pp. 8263-8275
Closed Access | Times Cited: 19
Recent progress in orexin/hypocretin physiology and pharmacology
Jyrki P. Kukkonen
BioMolecular Concepts (2012) Vol. 3, Iss. 5, pp. 447-463
Open Access | Times Cited: 19
Jyrki P. Kukkonen
BioMolecular Concepts (2012) Vol. 3, Iss. 5, pp. 447-463
Open Access | Times Cited: 19
Cellular Localization of Orexin 1 Receptor in Human Hypothalamus and Morphological Analysis of Neurons Expressing the Receptor
Konstantina Vraka, D. Mytilinaios, Andreas P. Katsenos, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 592-592
Open Access | Times Cited: 5
Konstantina Vraka, D. Mytilinaios, Andreas P. Katsenos, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 592-592
Open Access | Times Cited: 5
International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
Jyrki P. Kukkonen, Laura H. Jacobson, Daniël Hoyer, et al.
Pharmacological Reviews (2024), pp. PHARMREV-000953
Open Access | Times Cited: 1
Jyrki P. Kukkonen, Laura H. Jacobson, Daniël Hoyer, et al.
Pharmacological Reviews (2024), pp. PHARMREV-000953
Open Access | Times Cited: 1
Targeting the orexinergic system: Mainly but not only for sleep-wakefulness therapies
Abdelaziz Ghanemi, Xintian Hu
Alexandria Journal of Medicine (2014) Vol. 51, Iss. 4, pp. 279-286
Open Access | Times Cited: 8
Abdelaziz Ghanemi, Xintian Hu
Alexandria Journal of Medicine (2014) Vol. 51, Iss. 4, pp. 279-286
Open Access | Times Cited: 8
The Human Orexin/Hypocretin Receptor Crystal Structures
Jie Yin, Daniel M. Rosenbaum
Current topics in behavioral neurosciences (2016), pp. 1-15
Open Access | Times Cited: 6
Jie Yin, Daniel M. Rosenbaum
Current topics in behavioral neurosciences (2016), pp. 1-15
Open Access | Times Cited: 6
Reinforcing properties of alcohol in rats: Progressive ratio licking performance reinforced with 66% alcohol
Joanna B. Thompson, Shannon E. Conrad, Julia L. Peterman, et al.
Physiology & Behavior (2021) Vol. 235, pp. 113393-113393
Closed Access | Times Cited: 5
Joanna B. Thompson, Shannon E. Conrad, Julia L. Peterman, et al.
Physiology & Behavior (2021) Vol. 235, pp. 113393-113393
Closed Access | Times Cited: 5
Orexin receptors in GtoPdb v.2021.3
Paul J. Coleman, Luı́s de Lecea, Anthony L. Gotter, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2021) Vol. 2021, Iss. 3
Open Access | Times Cited: 4
Paul J. Coleman, Luı́s de Lecea, Anthony L. Gotter, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2021) Vol. 2021, Iss. 3
Open Access | Times Cited: 4
Non-peptide ligands in the characterization of peptide receptors at the interface between neuroendocrine and mental diseases
Margit Pissarek, Ulrich Disko
World Journal of Neuroscience (2013) Vol. 03, Iss. 02, pp. 100-125
Open Access | Times Cited: 3
Margit Pissarek, Ulrich Disko
World Journal of Neuroscience (2013) Vol. 03, Iss. 02, pp. 100-125
Open Access | Times Cited: 3
